China Pharma Holdings, Inc. (CPHI) Financials

CPHI Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2023 15.4 million 9.2 million
June 30, 2023 15.7 million 11.4 million
March 31, 2023 17.4 million 12.7 million
Dec. 31, 2022 17.8 million 13.5 million

CPHI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 1.0 million ?
June 30, 2023 -216435 ?
March 31, 2023 56.0 billion ?
Dec. 31, 2022 435180 78270

CPHI Net Income

No data available :(

CPHI Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 1.4 million - 134794
June 30, 2023 901910 - 152401
March 31, 2023 1.2 million - 20617
Dec. 31, 2022 2.0 million - 40445

CPHI Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 13.2 million
June 30, 2023 9.9 million
March 31, 2023 8.1 million
Dec. 31, 2022 6.4 million

CPHI Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 - 45773 246267 206524
June 30, 2023 - 23747 112033 169820
March 31, 2023 56.0 billion 23008 417999 144432
Dec. 31, 2022 149414 27999 829434 364397

CPHI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 1.8 million 2.0 million
June 30, 2023 1.1 million 1.2 million
March 31, 2023 2.0 million 1.8 million
Dec. 31, 2022 2.9 million 2.9 million

CPHI

Price: $0.87

52 week price:
0.50
2.60

Earnings Per Share: -1.02 USD

P/E Ratio: -0.59

Exchange: ASE

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: China

Volume: 955400

Market Capitalization: 1.6 million

Links: